← Back to Search

Artificial Intelligence

FUSION closed loop glucose control system for Type 2 Diabetes

N/A
Waitlist Available
Led By Francisco Pasquel, MD
Research Sponsored by Ideal Medical Technologies
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from beginning of use of the fusion system to end of use of the fusion system, which will be a period of time of up to 24 hours
Awards & highlights

Study Summary

This is a proof of concept safety study of an artificial intelligence based closed loop glucose control system designed for use in the intensive care unit setting. The type 2 diabetic subjects in this study will have their glucose controlled to a range of 100-140 mg/dL by a novel artificial intelligence based closed loop glucose control system for a period of 24 hours. The subjects will consume three standardized meals during the 24 hour study period.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from beginning of use of the fusion system to end of use of the fusion system, which will be a period of time of up to 24 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and from beginning of use of the fusion system to end of use of the fusion system, which will be a period of time of up to 24 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Primary Efficacy Outcome
Primary Safety Outcome
Secondary outcome measures
Glucose dispersion
Hyperglycemia
Severe hypoglycemia
+1 more
Other outcome measures
Average glucose value used by FUSION system versus from blood
Glucose

Trial Design

1Treatment groups
Experimental Treatment
Group I: FUSION closed loop glucose control systemExperimental Treatment1 Intervention
All subjects will be treated with the FUSION closed loop glucose control system for up to 24 hours
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
FUSION closed loop glucose control system
2022
N/A
~10

Find a Location

Who is running the clinical trial?

Ideal Medical TechnologiesLead Sponsor
1 Previous Clinical Trials
8 Total Patients Enrolled
Emory UniversityOTHER
1,636 Previous Clinical Trials
2,560,571 Total Patients Enrolled
Leon DeJournett, MDStudy DirectorIdeal Medical Technologies
1 Previous Clinical Trials
8 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Closed Loop Glucose Control in Patients With Type 2 Diabetes
2022. "Closed Loop Glucose Control in Patients With Type 2 Diabetes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05386849.
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top